ClinicalTrials.gg
Not yet recruitingNCT07824635Updated Sep 22, 2026

Neurobiology of Pain in Burn Survivors

An interventional study of Cognitive Behavioral Therapy and Pain Education in Burn, Chronic Pain and Pain Catastrophizing, sponsored by Spaulding Rehabilitation Hospital. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2026-09-22.

Sponsored by Spaulding Rehabilitation Hospital · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
92
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

Many burn survivors experience persistent, disabling pain that is strongly influenced by pain catastrophizing, a pattern of negative cognitive and emotional responses to pain involving feelings of helplessness, rumination, and magnification of symptoms. The primary purpose of this study is to evaluate whether an 6-week, remotely delivered cognitive-behavioral therapy program reduces pain interference (disruption to daily life) and pain catastrophizing more effectively than an 6-week pain education. Researchers also aim to identify the neurobiological mechanisms through which non-pharmacologic pain management works using functional Magnetic Resonance Imaging brain scans.

Read the detailed description

Pain is particularly prevalent (>50%) and disabling following burn injuries. Chronic pain is strongly modulated by negative affect, and pain catastrophizing, a pain-specific psychosocial construct comprising helplessness, pessimism, rumination, and magnification about pain-related symptoms, is a critical predictor of pain severity and treatment satisfaction. Non-pharmacologic interventions such as Cognitive Behavioral Therapy (CBT) improve pain partially by reducing catastrophizing. However, the underlying neurobiology supporting catastrophizing in burn injury survivors remains understudied. Identifying objective, catastrophizing-linked neural biomarkers may serve as important therapeutic targets and predict clinical treatment response.

This study is a randomized, longitudinal neuroimaging trial evaluating the mechanisms of CBT compared to an active educational control. Participants with chronic burn pain are randomized in a 1:1 ratio to undergo one of two 6-week, remotely delivered interventions:

  • CBT: Features 6 weekly 60-minute virtual sessions using active, structured cognitive-behavioral techniques. The intervention focuses on acquiring and practicing cognitive and emotional modulatory skills (e.g., relaxation, thought-stopping, distraction, cognitive restructuring) to reduce maladaptive pain-related cognitions.
  • Pain Education (EDU): An active control condition matched for professional contact time, consisting of 6 weekly virtual sessions covering general pain-related topics (e.g., Gate-Control Theory, pain types) without active pain-coping skill acquisition or home practice.

Assessments and Imaging:

Assessments take place at baseline, 6 weeks (post-intervention), and 24 weeks (follow-up).

  • Neuroimaging: Participants undergo 3-Tesla brain MRI sessions at baseline and 6 weeks, including structural MRI, resting-state fMRI, and a pain catastrophizing fMRI task.
  • fMRI Task: Patients view and reflect on statements from the Pain Catastrophizing Scale (PCS) intermixed with matched neutral statements in a block design during functional scanning.
  • Sensory and Clinical Measures: Baseline visits include Quantitative Sensory Testing (QST) via cuff pressure algometry.
  • Validated questionnaires are administered at all timepoints to measure pain interference (Brief Pain Inventory), catastrophizing (PCS), coping, self-efficacy, and general psychosocial functioning (PROMIS-29).

Study Aims

  • Aim 1: Investigate the association between brain processing of catastrophizing and individual differences in pain intensity and interference among burn-injury survivors. H1.1: Patients with more burn-associated pain and worse interference will show greater catastrophizing-induced activation in posterior cingulate cortex (PCC). H1.2: Patients with more pain and interference will also show greater catastrophizing-induced connectivity between PCC and salience network regions, such as anterior mid-cingulate cortex (aMCC).
  • Aim 2: Evaluate whether CBT (compared to pain education (EDU)) results in greater improvement in pain and catastrophizing, and reduced brain response to catastrophizing cues. H2.1: Patients randomized to CBT, compared to EDU, will report greater reductions in pain interference and catastrophizing. H2.2: Patients randomized to CBT, compared to EDU, will show greater reduction in PCC responses to catastrophizing cues. H2.3: Greater reduction in catastrophizing will be correlated with greater reduction in PCC responses.
  • Aim 3: Determine whether baseline PCC response to catastrophizing cues (after controlling for patient-reported catastrophizing scores) predicts improvement in pain outcomes following CBT, and whether changes in PCC catastrophizing response mediate changes in pain outcomes. H3.1: Based on our preliminary data, greater aMCC activation and PCC-to-aMCC connectivity response to catastrophizing cues at baseline will predict greater reductions in pain interference and catastrophizing following CBT (but not EDU). H3.2: Change in catastrophizing cue PCC responses following therapy will mediate the improvements in pain interference following CBT (versus EDU).
02

Conditions studied

  • Burn
  • Chronic Pain
  • Pain Catastrophizing

Keywords

  • Burn Injury
  • Cognitive Behavioral Therapy
  • fMRI
03

In context

Burns

905 studies on the registry are indexed under Burns; 164 are open to participants now.

This study's planned enrollment of 92 is above the median of 40 across 663 interventional studies indexed under Burns.

Browse Burns studies →

Lead sponsor

Spaulding Rehabilitation Hospital is the lead sponsor of 117 studies on the registry; 27 are open to participants now.

Of its 20 completed or terminated interventional studies of FDA-regulated products, 17 (85%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Previously hospitalized for burn injury
  • Age 18 to 65 years
  • Able to provide written and fluent in English
  • Living in a community setting
  • Six (6) months or more post-burn injury
  • Burn-related pain rated as ≥4 (on a scale of 0-10) over the past week, co-localized with the site of the burn injury

Exclusion criteria

Exclusion Criteria:

  • Comorbid acute pain condition.
  • Comorbid chronic pain condition that is rated by the participant as more painful than the burn injury pain.
  • Living in an institution or medical facility.
  • Pregnant or nursing.
  • Any psychiatric condition precluding study participation, such as a disorder involving psychosis (e.g., schizophrenia), unmanaged bipolar disorder, or a severe personality disorder.
  • History of anxiety disorders or significant anxiety symptoms interfering with imaging procedures (e.g., panic).
  • to MRI (e.g., implanted ferrous metal).
  • History of significant head injury (e.g., with substantial loss of consciousness).
  • Psychiatric hospitalization in the past 6 months.
  • Currently participating in therapeutic clinical research trials.
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Investigator, Outcomes assessor)
Enrollment
92 participants (estimated)

Study arms

  • Experimental
    Cognitive Behavioral Therapy

    Participants receive an 6-week course of remotely delivered Cognitive Behavioral Therapy via secure video conferencing (1 weekly session, approximately 60 minutes each). The intervention focuses on a pain self-management paradigm, cognitive restructuring, and skill-building exercises (e.g., relaxation, thought-stopping, distraction) along with in-vivo and home practice to target and reduce maladaptive pain-related cognitions.

    Behavioral: Cognitive Behavioral Therapy

  • Active comparator
    Pain Education

    Participants receive an 6-week course of remotely delivered Pain Education via secure video conferencing (1 weekly session, approximately 60 minutes each). Sessions cover general pain-related topics (e.g., Gate-Control Theory, acute vs. chronic pain, working with health care providers) without incorporating active coping skills training, handouts, or at-home practice.

    Behavioral: Pain Education

Interventions

  • BehavioralCognitive Behavioral Therapy

    An 6-week, remotely delivered behavioral intervention administered weekly via secure video conferencing by a trained psychologist (approximately 60 minutes per session). It utilizes active, structured techniques (such as relaxation, thought-stopping, distraction, and cognitive restructuring) along with in-vivo and home practice to target and reduce maladaptive pain-related cognitions (i.e., pain catastrophizing).

  • BehavioralPain Education

    An 6-week, remotely delivered educational control intervention administered weekly via secure video conferencing by a trained psychologist (approximately 60 minutes per session). Matched for therapist contact time with the Cognitive Behavioral Therapy group, sessions cover standard pain-related topics (e.g., Gate-Control Theory, types of chronic pain, working with healthcare providers) without active skill-building components, handouts, or at-home practice.

06

What researchers measure

Primary outcomes

  1. fMRI Measure

    Participants will undergo functional MRI scan sessions, including resting-state fMRI and task-based BOLD fMRI. Task-based fMRI utilizes a block-design contrasting 6 Pain Catastrophizing Scale statements (covering helplessness, magnification, and rumination) against 6 lexically matched neutral control statements.

    Time frame: Baseline and 6 weeks (post-intervention).

Secondary outcomes

  1. Pain Catastrophizing Scale (PCS)

    The Pain Catastrophizing Scale (PCS) will be used to evaluate negative cognitive-emotional responses to pain across three subscales: helplessness, magnification, and rumination. Scores range from 0 to 52, with higher scores indicating greater pain catastrophizing (worse outcome).

    Time frame: Baseline, 6 weeks (post-intervention), and 24 weeks (follow-up).

  2. Brief Pain Inventory (BPI)

    Measured using the Brief Pain Inventory (BPI) Pain Interference subscale. Evaluates how pain impacts daily activities, mood, mobility, work, relationships, sleep, and enjoyment of life on a scale of 0 to 10, where higher scores indicate greater pain interference (worse outcome).

    Time frame: Baseline, 6 weeks (post-intervention), and 24 weeks (follow-up)

Other outcomes

  1. Patient-Reported Outcomes Measurement Information System (PROMIS-29)

    Measured using the 29-item Patient Reported Outcomes Measurement Information System (PROMIS-29). Evaluates sub-scores for physical function, fatigue, sleep disturbance, social participation, depression, and anxiety.

    Time frame: Baseline, 6 weeks (post-intervention), and 24 weeks (follow-up).

  2. Quantitative Sensory Testing (QST) Battery

    An in-person somatosensory assessment utilizing calf cuff pressure algometry to evaluate individual pain thresholds (mild, moderate, and high pain) as well as dynamic pain mechanisms, including temporal summation of pain and conditioned pain modulation.

    Time frame: Baseline, and 6 weeks (post-intervention).

  3. Coping Strategies Questionnaire

    Assesses cognitive and behavioral strategies used to cope with pain, including distraction, coping self-statements, and other pain management approaches. Higher scores indicate greater use of the specified coping strategy.

    Time frame: Baseline, 6 weeks (post-intervention), and 24 weeks (follow-up)

  4. Pain Self-Efficacy Scale

    Assesses an individual's confidence in their ability to perform daily activities, achieve goals, and manage the consequences of chronic pain. Higher scores indicate greater pain self-efficacy.

    Time frame: Baseline, 6 weeks (post-intervention), and 24 weeks (follow-up)

  5. Working Alliance Inventory (WAI)

    Evaluates the strength, collaborative quality, and therapeutic bond formed between the participant and the interventionist.

    Time frame: 6 weeks (post-intervention).

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • MacKinnon DP, Lockwood CM, Hoffman JM, West SG, Sheets V. A comparison of methods to test mediation and other intervening variable effects. Psychol Methods. 2002 Mar;7(1):83-104. doi: 10.1037/1082-989x.7.1.83. PubMed 11928892 ↗
  • McLaren DG, Ries ML, Xu G, Johnson SC. A generalized form of context-dependent psychophysiological interactions (gPPI): a comparison to standard approaches. Neuroimage. 2012 Jul 16;61(4):1277-86. doi: 10.1016/j.neuroimage.2012.03.068. Epub 2012 Mar 30. PubMed 22484411 ↗
  • Gorgolewski KJ, Auer T, Calhoun VD, Craddock RC, Das S, Duff EP, Flandin G, Ghosh SS, Glatard T, Halchenko YO, Handwerker DA, Hanke M, Keator D, Li X, Michael Z, Maumet C, Nichols BN, Nichols TE, Pellman J, Poline JB, Rokem A, Schaefer G, Sochat V, Triplett W, Turner JA, Varoquaux G, Poldrack RA. The brain imaging data structure, a format for organizing and describing outputs of neuroimaging experiments. Sci Data. 2016 Jun 21;3:160044. doi: 10.1038/sdata.2016.44. PubMed 27326542 ↗
  • Lazaridou A, Kim J, Cahalan CM, Loggia ML, Franceschelli O, Berna C, Schur P, Napadow V, Edwards RR. Effects of Cognitive-Behavioral Therapy (CBT) on Brain Connectivity Supporting Catastrophizing in Fibromyalgia. Clin J Pain. 2017 Mar;33(3):215-221. doi: 10.1097/AJP.0000000000000422. PubMed 27518491 ↗
  • Ben-David BM, van Lieshout PH, Leszcz T. A resource of validated affective and neutral sentences to assess identification of emotion in spoken language after a brain injury. Brain Inj. 2011;25(2):206-20. doi: 10.3109/02699052.2010.536197. Epub 2010 Nov 30. PubMed 21117915 ↗
  • Polianskis R, Graven-Nielsen T, Arendt-Nielsen L. Computer-controlled pneumatic pressure algometry--a new technique for quantitative sensory testing. Eur J Pain. 2001;5(3):267-77. doi: 10.1053/eujp.2001.0245. PubMed 11558982 ↗
  • Petersen KK, Kilic K, Hertel E, Sejersgaard-Jacobsen TH, Jorgensen MK, Troelsen A, Arendt-Nielsen L, Boye Larsen D. Quantitative sensory testing as an assessment tool to predict the response to standard pain treatment in knee osteoarthritis: a systematic review and meta-analysis. Pain Rep. 2023 Jun 5;8(4):e1079. doi: 10.1097/PR9.0000000000001079. eCollection 2023 Jul-Aug. PubMed 38699564 ↗
  • Georgopoulos V, Akin-Akinyosoye K, Zhang W, McWilliams DF, Hendrick P, Walsh DA. Quantitative sensory testing and predicting outcomes for musculoskeletal pain, disability, and negative affect: a systematic review and meta-analysis. Pain. 2019 Sep;160(9):1920-1932. doi: 10.1097/j.pain.0000000000001590. PubMed 31045746 ↗
  • Harden RN, Weinland SR, Remble TA, Houle TT, Colio S, Steedman S, Kee WG; American Pain Society Physicians. Medication Quantification Scale Version III: update in medication classes and revised detriment weights by survey of American Pain Society Physicians. J Pain. 2005 Jun;6(6):364-71. doi: 10.1016/j.jpain.2005.01.350. PubMed 15943958 ↗
  • Devilly GJ, Borkovec TD. Psychometric properties of the credibility/expectancy questionnaire. J Behav Ther Exp Psychiatry. 2000 Jun;31(2):73-86. doi: 10.1016/s0005-7916(00)00012-4. PubMed 11132119 ↗
  • Andrusyna TP, Tang TZ, DeRubeis RJ, Luborsky L. The factor structure of the working alliance inventory in cognitive-behavioral therapy. J Psychother Pract Res. 2001 Summer;10(3):173-8. PubMed 11402080 ↗
  • Deyo RA, Katrina Ramsey, Buckley DI, Michaels L, Kobus A, Eckstrom E, Forro V, Morris C. Performance of a Patient Reported Outcomes Measurement Information System (PROMIS) Short Form in Older Adults with Chronic Musculoskeletal Pain. Pain Med. 2016 Feb;17(2):314-24. doi: 10.1093/pm/pnv046. PubMed 26814279 ↗
  • Revicki DA, Chen WH, Harnam N, Cook KF, Amtmann D, Callahan LF, Jensen MP, Keefe FJ. Development and psychometric analysis of the PROMIS pain behavior item bank. Pain. 2009 Nov;146(1-2):158-69. doi: 10.1016/j.pain.2009.07.029. Epub 2009 Aug 15. PubMed 19683873 ↗
  • Yu L, Buysse DJ, Germain A, Moul DE, Stover A, Dodds NE, Johnston KL, Pilkonis PA. Development of short forms from the PROMIS sleep disturbance and Sleep-Related Impairment item banks. Behav Sleep Med. 2011 Dec 28;10(1):6-24. doi: 10.1080/15402002.2012.636266. PubMed 22250775 ↗
  • Anderson KO, Dowds BN, Pelletz RE, Edwards TW, Peeters-Asdourian C. Development and initial validation of a scale to measure self-efficacy beliefs in patients with chronic pain. Pain. 1995 Oct;63(1):77-83. doi: 10.1016/0304-3959(95)00021-J. PubMed 8577493 ↗
  • Dworkin RH, Turk DC, Farrar JT, Haythornthwaite JA, Jensen MP, Katz NP, Kerns RD, Stucki G, Allen RR, Bellamy N, Carr DB, Chandler J, Cowan P, Dionne R, Galer BS, Hertz S, Jadad AR, Kramer LD, Manning DC, Martin S, McCormick CG, McDermott MP, McGrath P, Quessy S, Rappaport BA, Robbins W, Robinson JP, Rothman M, Royal MA, Simon L, Stauffer JW, Stein W, Tollett J, Wernicke J, Witter J; IMMPACT. Core outcome measures for chronic pain clinical trials: IMMPACT recommendations. Pain. 2005 Jan;113(1-2):9-19. doi: 10.1016/j.pain.2004.09.012. No abstract available. PubMed 15621359 ↗
  • Tan G, Jensen MP, Thornby JI, Shanti BF. Validation of the Brief Pain Inventory for chronic nonmalignant pain. J Pain. 2004 Mar;5(2):133-7. doi: 10.1016/j.jpain.2003.12.005. PubMed 15042521 ↗
  • Jensen MP, Turner JA, Romano JM. Changes in beliefs, catastrophizing, and coping are associated with improvement in multidisciplinary pain treatment. J Consult Clin Psychol. 2001 Aug;69(4):655-62. doi: 10.1037//0022-006x.69.4.655. PubMed 11550731 ↗
  • Burns JW, Kubilus A, Bruehl S, Harden RN, Lofland K. Do changes in cognitive factors influence outcome following multidisciplinary treatment for chronic pain? A cross-lagged panel analysis. J Consult Clin Psychol. 2003 Feb;71(1):81-91. doi: 10.1037//0022-006x.71.1.81. PubMed 12602428 ↗
  • Edwards RR, Haythornthwaite JA, Smith MT, Klick B, Katz JN. Catastrophizing and depressive symptoms as prospective predictors of outcomes following total knee replacement. Pain Res Manag. 2009 Jul-Aug;14(4):307-11. doi: 10.1155/2009/273783. PubMed 19714271 ↗
  • Severeijns R, van den Hout MA, Vlaeyen JW, Picavet HS. Pain catastrophizing and general health status in a large Dutch community sample. Pain. 2002 Sep;99(1-2):367-76. doi: 10.1016/s0304-3959(02)00219-1. PubMed 12237216 ↗
  • Osman A, Barrios FX, Kopper BA, Hauptmann W, Jones J, O'Neill E. Factor structure, reliability, and validity of the Pain Catastrophizing Scale. J Behav Med. 1997 Dec;20(6):589-605. doi: 10.1023/a:1025570508954. PubMed 9429990 ↗
  • Van Loey NE, Klein-Konig I, de Jong AEE, Hofland HWC, Vandermeulen E, Engelhard IM. Catastrophizing, pain and traumatic stress symptoms following burns: A prospective study. Eur J Pain. 2018 Jul;22(6):1151-1159. doi: 10.1002/ejp.1203. Epub 2018 Mar 9. PubMed 29436110 ↗
  • Rassu FS, Staguhn E, Ravyts S, Castillo R, Wiechman SA, Kirkhart T, Aaron RV, Acton A, Ware L, Milner SM, Price LA, Fauerbach JA, Haythornthwaite JA, Wegener ST. Efficacy of an online self-management program for chronic burn pain: A randomized controlled trial of the Take Charge of Burn Pain program. Burns. 2025 Mar;51(2):107336. doi: 10.1016/j.burns.2024.107336. Epub 2024 Dec 3. PubMed 39721239 ↗
  • Cukor J, Wyka K, Leahy N, Yurt R, Difede J. The treatment of posttraumatic stress disorder and related psychosocial consequences of burn injury: a pilot study. J Burn Care Res. 2015 Jan-Feb;36(1):184-92. doi: 10.1097/BCR.0000000000000177. PubMed 25407385 ↗
  • Seehausen A, Ripper S, Germann G, Hartmann B, Wind G, Renneberg B. Efficacy of a burn-specific cognitive-behavioral group training. Burns. 2015 Mar;41(2):308-16. doi: 10.1016/j.burns.2014.07.006. Epub 2014 Oct 7. PubMed 25300755 ↗
  • Lee J, Lazaridou A, Paschali M, Loggia ML, Berry MP, Ellingsen DM, Isenburg K, Anzolin A, Grahl A, Wasan AD, Napadow V, Edwards RR. A Randomized Controlled Neuroimaging Trial of Cognitive Behavioral Therapy for Fibromyalgia Pain. Arthritis Rheumatol. 2024 Jan;76(1):130-140. doi: 10.1002/art.42672. Epub 2023 Nov 21. PubMed 37727908 ↗
  • Burns JW, Glenn B, Bruehl S, Harden RN, Lofland K. Cognitive factors influence outcome following multidisciplinary chronic pain treatment: a replication and extension of a cross-lagged panel analysis. Behav Res Ther. 2003 Oct;41(10):1163-82. doi: 10.1016/s0005-7967(03)00029-9. PubMed 12971938 ↗
  • Haythronthwaite JA, Lawrence JW, Fauerbach JA. Brief cognitive interventions for burn pain. Ann Behav Med. 2001 Winter;23(1):42-9. doi: 10.1207/S15324796ABM2301_7. PubMed 11302355 ↗
  • Edwards RR, Cahalan C, Mensing G, Smith M, Haythornthwaite JA. Pain, catastrophizing, and depression in the rheumatic diseases. Nat Rev Rheumatol. 2011 Apr;7(4):216-24. doi: 10.1038/nrrheum.2011.2. Epub 2011 Feb 1. PubMed 21283147 ↗
  • Dauber A, Osgood PF, Breslau AJ, Vernon HL, Carr DB. Chronic persistent pain after severe burns: a survey of 358 burn survivors. Pain Med. 2002 Mar;3(1):6-17. doi: 10.1046/j.1526-4637.2002.02004.x. PubMed 15102213 ↗
  • Kim J, Loggia ML, Edwards RR, Wasan AD, Gollub RL, Napadow V. Sustained deep-tissue pain alters functional brain connectivity. Pain. 2013 Aug;154(8):1343-51. doi: 10.1016/j.pain.2013.04.016. Epub 2013 Apr 11. PubMed 23718988 ↗

Individual participant data

Plan to share: Yes — De-identified individual participant data may be shared with external research collaborators upon request, subject to an IRB-approved Data Use Agreement (DUA).

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 22, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07824635
Responsible party
Jeffrey Schneider (Associate Professor, Harvard Medical School, Spaulding Rehabilitation Hospital) — Principal investigator
First posted
Sep 17, 2026
Start date
Jan 2027 (estimated)
Primary completion
Jun 2031 (estimated)
Completion
Oct 2031 (estimated)
Last update
Sep 22, 2026

Study contacts

Jeffrey C. Schneider, MD
Contact
JCSCHNEIDER@MGH.HARVARD.EDU
6179526329

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion